Faouzi Saliba
- Hepatology top 0.1%
- Liver Disease and Transplantation 42
- Hepatocellular Carcinoma Treatment and Prognosis 11
- Hepatitis C virus research 9
- Transplantation top 1%
- Renal Transplantation Outcomes and Treatments 31
- Epidemiology top 0.5%
- Liver Disease Diagnosis and Treatment 24
- Hepatitis B Virus Studies 6
- Pharmacology top 0.5%
- Surgery top 1%
- Organ Transplantation Techniques and Outcomes 49
- Transplantation: Methods and Outcomes 7
Faouzi Saliba
91 papers receiving 4.4k citations
Hit Papers
Peers
Comparison fields: 5 of 96
- Hepatology 3.7k
- Transplantation 370
- Epidemiology 2.6k
- Pharmacology 661
- Surgery 2.1k
Countries citing papers authored by Faouzi Saliba
This map shows the geographic impact of Faouzi Saliba's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Faouzi Saliba with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Faouzi Saliba more than expected).
Fields of papers citing papers by Faouzi Saliba
This network shows the impact of papers produced by Faouzi Saliba. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Faouzi Saliba. The network helps show where Faouzi Saliba may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Faouzi Saliba, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | 2023 | 2 | |
| 3 | 2023 | 7 | |
| 4 | 2023 | 1 | |
| 5 | 2023 | 8 | |
| 6 | 2021 | 16 | |
| 7 | 2021 | 5 | |
| 8 | 2018 | 4 | |
| 9 | Bacterial and fungal infections in acute-on-chronic liver failure: prevalence, characteristics and impact on prognosisbreakdown → | 2017 | 358 |
| 10 | 2017 | 66 | |
| 11 | 2017 | 6 | |
| 12 | 2015 | 84 | |
| 13 | 2014 | 11 | |
| 14 | Everolimus Based Immunosuppression in Hepatitis C Virus Positive De Novo Liver Transplant Recipients: 24 Month Results from a Randomized Controlled Trial | 2013 | 3 |
| 15 | Everolimus with early reduction or elimination of tacrolimus in 719 de novo liver transplant recipients - 12 month efficacy and safety results from the H2304 study | 2012 | 1 |
| 16 | Renal function with everolimus and reduced tacrolimus in de novo liver transplant recipients: 12 month results of the H2304 trial. O-17 | 2012 | 5 |
| 17 | Evolution of Renal Function with Early Everolimus-Facilitated Reduction or Elimination of Tacrolimus in 719 De Novo Liver Transplant Recipients: 12 Month Data of the H2304 Study | 2012 | 1 |
| 18 | 2011 | 61 | |
| 19 | Everolimus in De Novo Liver Transplant Recipients To Either Minimize or Eliminate Tacrolimus - Study Design and Update | 2010 | 1 |
| 20 | [Fatal fulminating hepatitis due to Herpes simplex virus type 2 in a young immunocompetent female]. | 1999 | 3 |
About Faouzi Saliba
Faouzi Saliba is a scholar working on Transplantation, Hepatology and Surgery, having authored 94 papers that have together received 4.5k indexed citations. Recurring topics across this work include Organ Transplantation Techniques and Outcomes (49 papers), Liver Disease and Transplantation (42 papers), Renal Transplantation Outcomes and Treatments (31 papers), Liver Disease Diagnosis and Treatment (24 papers), Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Hepatitis C virus research (9 papers), Transplantation: Methods and Outcomes (7 papers) and Hepatitis B Virus Studies (6 papers). The work is most often cited by research in Hepatology (3.7k citations), Transplantation (370 citations) and Epidemiology (2.6k citations). Faouzi Saliba has collaborated with scholars based in France, United States and United Kingdom. Frequent co-authors include Didier Samuel, Marco Pavesi, Pere Ginès, Rajiv Jalan, Thierry Gustot, Vicente Arroyo, François Durand, Marco Domenicali, Jonel Trebicka and Alexander Gerbes. Their work appears in journals such as Journal of Clinical Oncology, Blood and Annals of Internal Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.